Today Opyl Ltd announced the signing of a partnership with NeuroEndocrine Cancer Australia with the goal of creating greater awareness about Neuroendocrine cancer and access to clinical trials. We are really looking forward to tapping into the Opin platform and the possibilities it will provide. The future looks bright.
To read more about this announcement click here.
